Independently of whether aberrant NOTCH1 signaling is the result of genetic alterations or of a permissive environment, this pathway plays a critical role in CLL pathogenesis and progression and could represent a suitable therapeutic target. The gene discussed is NOTCH1; the disease is B-cell chronic lymphocytic leukemia.